Thursday, May 8, 2025 – Gutgesell RM, Khalil A, Liskiewicz A, Maity-Kumar G, Novikoff A, Grandl G, Liskiewicz D, Coupland C, Karaoglu E, Akindehin S, Castelino R, Curion F, Liu X, Garcia-Caceres C, Cebrian-Serrano A, Douros JD, Knerr PJ, Finan…
Thursday, May 8, 2025 – January 16, 2025Thyroid Vol 35, No. 1 This research article investigates the potential link between glucagon-like peptide 1 receptor agonists (GLP1-RAs), medications used for type 2 diabetes, and the risk of developing thyroid cancer. Conducted as a large,…
Wednesday, May 7, 2025 – Released: January 7, 2025Level 1 GuidanceDraft This draft guidance document from the U.S. Food and Drug Administration (FDA) outlines recommendations for the development of drugs and biological products intended for weight reduction and maintenance in both adult and pediatric patients with obesity or…
Sunday, May 4, 2025 – by Daniel J Drucker Nature Reviews Drug Discovery Drucker DJ. GLP-1-based therapies for diabetes, obesity and beyond. Nat Rev Drug Discov. 2025 Apr 25. doi: 10.1038 Epub ahead of print. PMID: 40281304. This review article discusses GLP-1-based therapies,…
Saturday, May 3, 2025 – The company’s health services division Evernorth is unveiling new programs in a reliable growth area: assuaging payer concerns around GLP-1 coverage. Dive Brief: This article focuses on Cigna’s strategies regarding the growing demand for GLP-1 weight loss medications.…
Thursday, May 1, 2025 – That’s the question researchers aim to answer in a new, first-of-its-kind, clinical trial in North Texas By Bianca Castro • Published April 30, 2025 • Updated on April 30, 2025 at 10:52 pm Researchers in Dallas are investigating the potential of weight loss medications,…
Tuesday, April 29, 2025 – Yaacobi Peretz, S., Kessner, R., Bar, Y. et al. Body composition metrics as a determinant of trastuzumab deruxtecan related toxicity and response. npj Breast Cancer 11, 38 (2025). This scientific article explores the connection between a patient’s body…
Sunday, April 27, 2025 – by Jennifer H Hwang, DO; Neda Laiteerapong, MD; Elbert S. Huang, MD; David D. Kim, PhDJAMA Health Forum: 2025 Mar 7;6(3):e245586. doi: 10.1001 Published March 14, 2025 This research evaluates the cost-effectiveness of four different antiobesity medications compared to…
Saturday, April 26, 2025 – by Michael Monostra Fact Checked by Richard Smith from Endocrine Today/Healio NewsPublished April 25, 2025 According to findings from a microsimulation model, covering obesity medications under Medicare Part D is projected to significantly increase federal spending, estimated at $47.7…
Friday, April 25, 2025 – American Heart Association by Laura Williamson, American Heart Association NewsPublished: January 14, 2025 The American Heart Association discusses healthspan, defining it as the number of years one lives free from significant chronic disease or disability, and…